Consistent with this, a study by Wang et al. [38] also showed that simvastatin monotherapy increased p21 and p27 by decreasing skp2 leading to the activation of AMPK in hepatocellular carcinoma. This evidence concerns the gene SKP2 and hepatocellular carcinoma.